These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens. Zhou J; Liu B; Geng G; Wu JH Proteins; 2010 Feb; 78(3):623-37. PubMed ID: 19787772 [TBL] [Abstract][Full Text] [Related]
5. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. Bohl CE; Miller DD; Chen J; Bell CE; Dalton JT J Biol Chem; 2005 Nov; 280(45):37747-54. PubMed ID: 16129672 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics. Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028 [TBL] [Abstract][Full Text] [Related]
7. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938 [TBL] [Abstract][Full Text] [Related]
8. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related]
9. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines. Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines. Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511 [TBL] [Abstract][Full Text] [Related]
11. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349 [TBL] [Abstract][Full Text] [Related]
12. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690 [TBL] [Abstract][Full Text] [Related]